Secondary Prevention Education After Acute Myocardial Infarction

NCT ID: NCT04769219

Last Updated: 2024-01-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

86 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-01

Study Completion Date

2021-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to examine the effect of secondary prevention education given to individuals after acute myocardial infarction on physiological parameters, anxiety and quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to examine the effect of secondary prevention education given to individuals after acute myocardial infarction on physiological parameters, anxiety and quality of life.The population of the study will be the individuals hospitalized with the diagnosis of acute myocardial infarction in the Coronary Intensive Care Unit of Abant Izzet Baysal University Izzet Baysal Training and Research Hospital. The study will be conducted in a randomized controlled manner with two groups, 43 in the control group and 43 in the secondary prevention education group. CAG (Coronary Angiography) Procedure Training Form, Patient Identification Form, Physiological Parameters Form and Visual Analogue Scale, Spielberg State and Trait Anxiety Scale and Myocardial Infarction Dimensional Assessment Scale will be used to collect data. The data will be collected by face to face interview technique. For descriptive statistics, mean and standard deviation or median and minimum-maximum values for numerical variables, number and percentage values for categorical variables will be given. The Kolmogorov-Smirnov test (p \<0.05), skewness and kurtosis coefficients (should be ± 1) and X ̅ / SS \<4 inequalities will be examined at the same time, and the weight in which group will be preferred.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myocardial Infarction, Acute Anxiety Education Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

There are 2 groups as intervention and control
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants
the participant did not know which group he was in.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

secondary prevention training

Secondary prevention training will be given to 43 randomly selected patients between the fourth and sixth hours after AMI (in accordance with the patient's request). Secondary protection training will be carried out in two parts. First of all, the anatomical structure and functions of the heart, the definition of AMI, its causes, symptoms and risk factors will be explained, and then the issues to be considered after AMI will be explained. The content of the training will also be given to the participants in a written booklet.

Group Type EXPERIMENTAL

Secondary prevention training

Intervention Type OTHER

Secondary prevention training will be given after acute myocardial infarction

nursing care

43 randomly selected patients will form the control group and this group will be provided with routine care and follow-up in the clinic. No intervention will be made.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Secondary prevention training

Secondary prevention training will be given after acute myocardial infarction

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* First time AMI and inpatient treatment in the coronary intensive care unit,
* Not having received training after AMI \*
* Being 18 years or older,
* Speak Turkish,
* No problem in verbal communication,
* Absence of hearing loss,
* Not being diagnosed with a psychiatric illness,
* Being conscious,
* Being volunteer to participate in the study,
* Routine check of cholesterol, HDL, LDL, triglyceride results at the beginning of the study and at 6 months.

Exclusion Criteria

Not having had AMI for the first time

* Having received training after AMI
* Not willing to participate in the study,
* Cannot speak Turkish,
* Problems in verbal communication,
* Having hearing loss,
* Having a diagnosis of psychiatric illness,
* Unconsciousness.
* Cholesterol, HDL, LDL, triglyceride results were not routinely checked at the start and 6 months of the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abant Izzet Baysal University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

saadet can çiçek, Dr

Role: PRINCIPAL_INVESTIGATOR

Abant Izzet Baysal University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Abant İzzet Baysal University

Merkez, Bolu, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AIBU-KYB-AYN-02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Teach-Back Method in Angiography
NCT06959303 ENROLLING_BY_INVITATION NA